Pharynx
Pharynx
Active defense against infections – Upper respiratory tract infections
A cold is an acute infection of the upper respiratory tract, usually caused by a virus. Typical symptoms are cough, runny nose, hoarseness and sore throat. Pharynx is a newly developed medical device Class I according to 93/42/EEC, manufactured by Nutrin GmbH (Germany) and distributed in Greece by A.S.K. PHARMACEUTICAL Μ.ΕΠΕ, containing a unique active ingredient complex, consisting of hyaluronic acid and sea buckthorn extract. The special hyaluronic complex covers and supports the irritated mucous membranes like a protective film. The mucous membranes are soothed and protected from possible external stimuli. The natural defense function of the mucous membrane is supported and further enhanced by the natural barrier, making it more difficult for new bacteria and viruses to invade. Due to this natural mechanism of action, there is no tolerance effect.
Sea buckthorn is a very strong plant having its origin in the Himalayas. Sea buckthorn fruit contains sugars, sugar alcohols, fruit acids, vitamins (C, E, and K), polyphenols, carotenoids, fiber, amino acids, minerals, and plant sterols.
Suitability
Supports the natural barrier function of the mucous of the mouth and throat against infectious viruses and bacteria in a physical way
Protects and soothes the mucous membrane of the mouth, throat and pharynx against viruses
Relieves throat irritation, hoarseness and sore throat
Relieves cough and dry cough
Relieves throat in case the voice is used to a great extent
Soothes throat and mouth in case of dry air due to heating or air conditioning
Soothes throat and mouth in case of smoking
Warnings
- What you should know before taking Pharynx
- Please read the enclosed instructions carefully!
- Do not take if you are allergic to any of the ingredients.
- Do not take if you have intolerance to some sugars (e.g. sorbitol, maltitol).
- Do not take while lying down (e.g. while getting ready to sleep).
- Due to swallowing risk, the product is not recommended for use in children under 6 years old.
- Not recommended for patients with severely limited saliva production (e.g. Sjörgen Syndrome) or
swallowing disorders. - Patients receiving anticoagulants should receive Pharynx lozenges after consulting their physician
and should not exceed the recommended dosage. (3 lozenges daily) - If there is no improvement 2-3 days after the start of treatment or if symptoms aggravate
significantly (e.g. with the onset of fever 38 o C), you should seek medical advice.
EOF Registration Number: 2820008682842
